간편하게 보는 뉴스는 유니콘뉴스
기사검색
인기 검색어 메모리 모니터 생존
검색어 "WHO"
뉴스기사물 (10)
BOSTON--(Business Wire / Korea Newswire)--Access Advance (“Advance”) is pleased to welcome Hyundai Motor Company (“Hyundai”) and Kia as Licensors of the VVC Advance Patent Pool. By contributing their patents to the VVC/H.266 patent pool,...
OSAKA, JAPAN & CAMBRIDGE, MASS.--(Business Wire / Korea Newswire)--Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved ADZYNMA®▼ (recombinant ADAMTS13) for the treatment of ADAMTS13 deficiency in children and adult patients with congenital...
TAMPA BAY, FLA.--(Business Wire / Korea Newswire)--KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced the results of its Q2 2024 top-clicked phishing report. The results include...
NEW YORK--(Business Wire / Korea Newswire)--Ultimate Risk Solutions (URS) is pleased to announce a global cooperation with Howden, who has become a new client for URS’ advanced risk-management suite. This suite covers economic and...
제휴회계/세무해외소프트웨어 뉴욕--(Business Wire / 뉴스와이어)--얼티밋 리스크 솔루션즈(Ultimate Risk Solutions, URS)는 하우덴(Howden)과 글로벌 협력 관계를 맺었다고 발표했다. 이로써 하우덴은 URS의 첨단 리스크 관리 제품군의 새로운 고객이 됐다. 이 제품군은 경제 및 규제 자본 관리, 자산 모델링,...
DUBLIN--(Business Wire / Korea Newswire)--Ilkari, the first truly sovereign technology company, today announced the launch of its industry-first, end-to-end data sovereignty solutions. These solutions empower businesses to build data sovereignty on their terms and...
LOS ANGELES--(Business Wire / Korea Newswire)--Point2Web, your ultimate marketing powerhouse in creative, advertising, and performance marketing, is thrilled to announce its appointment as the first Agency Sales Partner in Europe for NewsBreak, America's leading...
서울건강신상품경제 동향정부비영리조직 서울--(뉴스와이어)--서울시정신건강복지센터(이하 서울센터)는 중독성 약물 사용자의 급격한 증가로 치료·재활 서비스에 대한 사회적 요구와 필요성이 확대됨에 따라 지역사회 정신건강기관에서 활용 가능한 중독성 약물 사용 선별 및 자가관리 프로그램 ‘SBIRT-ASSIST’를 개발했다고 밝혔다. ...
OSAKA, JAPAN--(Business Wire / Korea Newswire)--Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the first quarter of fiscal year 2024 (period ended June 30, 2024), with continued momentum in its Growth & Launch Products driving...
BEIJING, CHINA & SOUTH SAN FRANCISCO, CALIF.--(Business Wire / Korea Newswire)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that it has...
API
fg
유니콘뉴스는 보도자료 배포 서비스입니다.
여기에 뉴스를 등록하면 언론이 보도하고 널리 배포됩니다.